Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Lupo, Philip J ^a   Goldmuntz, Elizabeth ^b   Mitchell, Laura E ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCOBALAMIN II;

AORTA ARCH ANOMALY; AORTA ARCH INTERRUPTION; ARTERIAL TRUNK; ARTICLE; CHILD; CONGENITAL HEART MALFORMATION; CONOTRUNCAL AND RELATED HEART DEFECT; FALLOT TETRALOGY; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; STATISTICAL MODEL;

CHILD; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HEART DEFECTS, CONGENITAL; HUMANS; LINEAR MODELS; MALE; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77950364444     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/630940     Document Type: Article

References (38)

1. L. D. Botto, A. Correa, and J. D. Erickson, "Racial and temporal variations in the prevalence of heart defects," Pediatrics, vol. 107, no. 3, p. E32, 2001.
2. A. Christianson, C. P. Howson, and B. Modell, Global Report on Birth Defects, March of Dimes, White Plains, NY, USA, 2006.
3. K. J. Jenkins, A. Correa, J. A. Feinstein, et al., "Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics," Circulation, vol. 115, no. 23, pp. 2995-3014, 2007. (Pubitemid 46912106)
4. M. E. Pierpont, C. T. Basson, D. W. Benson Jr., et al., "Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics," Circulation, vol. 115, no. 23, pp. 3015-3038, 2007. (Pubitemid 46912107)
5. P. S. Harper, Practical Genetic Counselling, Hodder Arnold, New York, NY, USA, 2004.
6. L. E. Mitchell and C. R. Weinberg, "Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the "pent" design," American Journal of Epidemiology, vol. 162, no. 7, pp. 676-685, 2005. (Pubitemid 41437367)
7. L. D. Botto, A. E. Lin, T. Riehle-Colarusso, S. Malik, and A. Correa, "Seeking causes: classifying and evaluating congenital heart defects in etiologic studies," Birth Defects Research Part A, vol. 79, no. 10, pp. 714-727, 2007. (Pubitemid 47584196)
8. E. Goldmuntz, S. Woyciechowski, D. Renstrom, et al., "Variants of folate metabolism genes and the risk of conotruncal cardiac defects," Circulation, vol. 1, pp. 126-132, 2008.
9. C. A. Hobbs, S. J. James, A. Parsian, et al., "Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene," Journal of Medical Genetics, vol. 43, no. 2, pp. 162-166, 2006. (Pubitemid 43259631)
10. G. M. Shaw, D. M. Iovannisci, W. Yang, et al., "Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes," American Journal of Medical Genetics, vol. 138, no. 1, pp. 21-26, 2005. (Pubitemid 41262639)
11. G. M. Shaw, W. Lu, H. Zhu, et al., "118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects," BMC Medical Genetics, vol. 10, article 49, 2009.
12. C. R. Weinberg, "Allowing for missing parents in genetic studies of case-parent triads," American Journal of Human Genetics, vol. 64, no. 4, pp. 1186-1193, 1999. (Pubitemid 30463050)
13. K.-A. da Costa, O. G. Kozyreva, J. Song, J. A. Galanko, L. M. Fischer, and S. H. Zeisel, "Common genetic polymorphisms affect the human requirement for the nutrient choline," FA SEB Journal, vol. 20, no. 9, pp. 1336-1344, 2006. (Pubitemid 44943841)
14. B. H. Rovin, L. Lu, and R. Saxena, "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression," Biochemical and Biophysical Research Communications, vol. 259, no. 2, pp. 344-348, 1999. (Pubitemid 29281234)
15. P. Frosst, H. J. Blom, R. Milos, et al., "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase," Nature Genetics, vol. 10, no. 1, pp. 111-113, 1995.
16. I. Weisberg, P. Tran, B. Christensen, S. Sibani, and R. Rozen, "A second genetic polymorphism in methylenetetrahydrofo-late reductase (MTHFR) associated with decreased enzyme activity," Molecular Genetics and Metabolism, vol. 64, no. 3, pp. 169-172, 1998. (Pubitemid 28453294)
17. D. L. Harmon, J. V. Woodside, J. W. G. Yarnell, et al., "The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocys-teinaemia," QJM, vol. 89, no. 8, pp. 571-577, 1996. (Pubitemid 26278868)
18. D. J. Gaughan, L. A. J. Kluijtmans, S. Barbaux, et al., "The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations," Atherosclerosis, vol. 157, no. 2, pp. 451-456, 2001. (Pubitemid 32710025)
19. S. G. Heil, N. M. J. van der Put, E. T. Waas, M. Den Heijer, F. J. M. Trijbels, and H. J. Blom, "Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?" Molecular Genetics and Metabolism, vol. 73, no. 2, pp. 164-172, 2001. (Pubitemid 32550154)
20. K. J. A. Lievers, L. A. Afman, L. A. J. Kluijtmans, et al., "Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients," Clinical Chemistry, vol. 48, no. 9, pp. 1383-1389, 2002. (Pubitemid 34925771)
21. L. A. J. Kluijtmans, G. H. J. Boers, F. J. M. Trijbels, H. M. A. van Lith-Zanders, L. P. W. J. van den Heuvel, and H. J. Blom, "A common 844INS68 insertion variant in the cystathionine β-synthase gene," Biochemical and Molecular Medicine, vol. 62, no. 1, pp. 23-25, 1997. (Pubitemid 27495276)
22. R. D. Kalmbach, S. F. Choumenkovitch, A. P. Troen, P. F. Jacques, R. D'Agostino, and J. Selhub, "A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate," Journal of Nutrition, vol. 138, no. 12, pp. 2323-2327, 2008.
23. H. Gellekink, H. J. Blom, I. J. M. van der Linden, and M. den Heijer, "Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels," European Journal of Human Genetics, vol. 15, no. 1, pp. 103-109, 2007. (Pubitemid 44921673)
24. H. Mei, M. L. Cuccaro, and E. R. Martin, "Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables," American Journal of Human Genetics, vol. 81, no. 6, pp. 1251-1261, 2007. (Pubitemid 350211453)
25. Q. Yang, M. J. Khoury, F. Sun, and W. D. Flanders, "Case-only design to measure gene-gene interaction," Epidemiology, vol. 10, no. 2, pp. 167-170, 1999. (Pubitemid 29093954)
26. L.-Y. Wang and W.-C. Lee, "Population stratification bias in the case-only study for gene-environment interactions," American Journal of Epidemiology, vol. 168, no. 2, pp. 197-201, 2008. (Pubitemid 351951599)
27. D. M. Umbach and C. R. Weinberg, "The use of case-parent triads to study joint effects of genotype and exposure," American Journal of Human Genetics, vol. 66, no. 1, pp. 251-261, 2000. (Pubitemid 30481487)
28. J. K. Vermunt, LEM: A General Program for the Analysis of Categorical Data, Tilberg University, Tilberg, The Netherlands, 1997.
29. C. R. Weinberg, A. J. Wilcox, and R. T. Lie, "A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting," American Journal of Human Genetics, vol. 62, no. 4, pp. 969-978, 1998. (Pubitemid 28194340)
30. V. M. Guillem, M. Collado, M. J. Terol, et al. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies," Leukemia, vol. 21(7) 1413-1422, 2007. (Pubitemid 46969870)
31. S. G. Reeves, C. Meldrum, C. Groombridge, et al., "MTHFR 677 C > T and 1298 C > T polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer," European Journal of Human Genetics, vol. 17, no. 5, pp. 629-635, 2009.
32. C. M. Summers, A. L. Hammons, L. E. Mitchell, et al., "Influence of the cystathionine β-synthase 844ins68 and methylenetetrahydrofolate reductase 677 C > T polymorphisms on folate and homocysteine concentrations," European Journal of Human Genetics, vol. 16, no. 8, pp. 1010-1013, 2008.
33. V. de Stefano, V. Dekou, V. Nicaud, et al., "Linkage disequilibrium at the cystathionine β synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine," Annals of Human Genetics, vol. 62, no. 6, pp. 481-490, 1998. (Pubitemid 29237670)
34. V. Dekou, V. Gudnason, E. Hawe, G. J. Miller, D. Stansbie, and S. E. Humphries, "Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men," Thrombosis and Haemostasis, vol. 85, no. 1, pp. 67-74, 2001. (Pubitemid 32050945)
35. L. D. Botto and P. Mastroiacovo, "Exploring gene-gene interactions in the etiology of neural tube defects," Clinical Genetics, vol. 53, no. 6, pp. 456-459, 1998. (Pubitemid 28327738)
36. E. Rampersaud, E. C. Melvin, D. Siegel, et al., "Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects," Clinical Genetics, vol. 63, no. 3, pp. 210-214, 2003. (Pubitemid 36949922)
37. B. Richter, K. Stegmann, B. Roper, et al., "Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population," Journal of Human Genetics, vol. 46, no. 3, pp. 105-109, 2001. (Pubitemid 32290637)
38. M. C. Speer, J. Nye, D. McLone, et al., "Possible interaction of genotypes at cystathionine β-synthase and methylenetetrahy-drofolate reductase (MTHFR) in neural tube defects," Clinical Genetics, vol. 56, no. 2, pp. 142-144, 1999. (Pubitemid 29433596)